Register for a Werfen Education Event

8:30–9:00 am: Registration and Breakfast

9:00–9:30 am: Werfen Welcome
Bree Brown, Area Business Manager, Werfen

9:30–10:30 am: 

Managing Hemolysis in Whole Blood at the Point of Care (POC)

Christopher Farnsworth, PhD
Assoc. Professor, Dept. of Pathology and Immunology
Washington University School of Medicine
Medical Director, Clinical Chemistry POCT
St. Louis, MO

Objectives

• Identify challenges in current practices for managing hemolysis at the POC
• Review how POC hemolysis detection compares to laboratory methods​
• Discuss the experience of detecting hemolysis at the POC, to improve quality of care​

10:30–11:30 am: Patient Blood Management: A Focus on Perioperative Coagulation Management in Cardiac Surgery and Liver Transplantation***‡

  Christopher Farnsworth, PhD
Assoc. Professor, Dept. of Pathology and Immunology
Washington University School of Medicine
Medical Director, Clinical Chemistry POCT
St. Louis, MO

Objectives

12:30–1:30 pm: Introducing the GEM® Premier^TM 7000 with iQM®3 w/ GEMweb Plus
Annette Batres, Werfen

1:30–2:30 pm: Instrument Demonstrations

3:00–3:30 pm: ROTEM sigma w/Verify Now
Ben Dussouy,  PBM Specialist, Werfen

3:30–4:30 pm: Improving Pre-Analytical Practices for Blood Gases and Related Analytes***‡
Andrew Mikhail, Applications Consultant, Werfen

Objectives

• Define common sources of pre-analytical error in blood gases and related analytes
• Recognize the potential for micro-clots to affect accuracy of blood gas results
• Describe practices to reduce the potential for pre-analytical error

10:30–11:00 am: Autoimmune Portfolio Overview
Jamie Villalpando, Sales Consultant, Werfen

11:00–11:30 am: Aptiva – Werfen’s Multiplex Technology System
Sabrina Miller, Clinical Autoimmune Specialist, Werfen

12:30–1:30 pm: Hep-2 Fundamentals and Pattern Interpretation***
Alexa Pederson, Clinical Autoimmune Specialist, Werfen

• List four common CTD and their symptoms​
• List the criteria needed for a HEp-2 IFA assay to perform well​​
• Explain why IgG Fc specific conjugate for HEp-2 assays is​ recommended by the CLSI for good laboratory practice​
• ​Name the basic HEp-2 IFA patterns

1:30–2:30 pm: Instrument Demonstrations

3:00-4:00 pm: Antiphospholipid Syndrome and Testing for Antiphospholipid Antibodies***
Sabrina Miller, Clinical Autoimmune Specialist, Werfen

Objectives

• Describe a recommended testing algorithm for APS​
• Explain the added value of anti-PS/PT testing​
• Explain the significance of risk stratification

4:00–5:00 pm: Instrument Demonstrations

10:30–11:00 am: Introducing the ACL TOP Family 70 Series
Dean Weeks, Executive Sales Consultant, Werfen

11:00–11:30 am: Instrument Demonstrations 

12:30–1:30 pm: Direct Oral Anticoagulants: Challenges in the Hemostasis Laboratory***
Geoff Chow, Clinical Specialist, Werfen

Objectives

• Understand direct oral anticoagulants (DOAC), including the benefits versus warfarin
• Understand the effect DOACs may have on Hemostasis assays
• Review current FDA-approved reversal agents for DOACs
• Describe laboratory methods used to measure DOAC concentration and when testing may be useful

1:30–2:30 pm: The Unique Advantages of Specialized Hemostasis Automation
Tony Barresi, Senior Product Manager, Automation, Werfen

3:00–4:00 pm: Pre-analytical challenges in Hemostasis testing***‡
Geoff Chow, Clinical Specialist, Werfen

Objectives

• Elucidate the effect common pre-analytical errors have on hemostasis assays
• Present correct collection and processing conditions for hemostasis samples
• Review new technologies to standardize unacceptable sample flagging and document compliance with quality standards (ISO 15189:2012)

 4:00-5:00 pm: Tips and Tricks – Troubleshooting

9:30–10:30 am: Transplant Welcome
Erik Chatroop, Regional Sales Manager, Werfen

10:40–11:00 am: User Experience: Validation of NanoTYPE 
Nicole Farris

10:30–11:00 am: Transplant Welcome
Dean Weeks, Executive Sales Consultant, Werfen

10:30–11:00 am: Transplant Welcome
Dean Weeks, Executive Sales Consultant, Werfen